Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2023-10-10

Clinical Trial Update: Predictors of AIS Unfavorable Outcomes [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating predictors of unfavorable outcomes after acute ischemic stroke treated with alteplase.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alteplase (alteplase)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Ischemic Stroke, Alteplase Adverse Reaction | Phase 4 | Status: COMPLETED